: What Merck’s antiviral pill could mean for vaccine hesitancy — ‘It’s not a magic pill’


Merck and Ridgeback Therapeutics say molnupiravir cuts the risk of death or hospitalization in half

Project Syndicate: America needs to be honest about its failings

Previous article

: Amazon-backed EV company Rivian files for IPO

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in News